These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12383006)

  • 61. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
    Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
    Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Molecular docking and 3D QSAR studies on 1-amino-2-phenyl-4-(piperidin-1-yl)-butanes based on the structural modeling of human CCR5 receptor.
    Xu Y; Liu H; Niu C; Luo C; Luo X; Shen J; Chen K; Jiang H
    Bioorg Med Chem; 2004 Dec; 12(23):6193-208. PubMed ID: 15519163
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The Universal 3D QSAR Model for Dopamine D
    Zięba A; Żuk J; Bartuzi D; Matosiuk D; Poso A; Kaczor AA
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540025
    [TBL] [Abstract][Full Text] [Related]  

  • 64. 3D-QSAR comparative molecular field analysis on opioid receptor antagonists: pooling data from different studies.
    Peng Y; Keenan SM; Zhang Q; Kholodovych V; Welsh WJ
    J Med Chem; 2005 Mar; 48(5):1620-9. PubMed ID: 15743203
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of the 5-HT4 receptor mediating tachycardia in piglet isolated right atrium.
    Medhurst AD; Kaumann AJ
    Br J Pharmacol; 1993 Nov; 110(3):1023-30. PubMed ID: 8298790
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mapping and fitting the peripheral benzodiazepine receptor binding site by carboxamide derivatives. Comparison of different approaches to quantitative ligand-receptor interaction modeling.
    Anzini M; Cappelli A; Vomero S; Seeber M; Menziani MC; Langer T; Hagen B; Manzoni C; Bourguignon JJ
    J Med Chem; 2001 Apr; 44(8):1134-50. PubMed ID: 11312914
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New selective and potent 5-HT(1B/1D) antagonists: chemistry and pharmacological evaluation of N-piperazinylphenyl biphenylcarboxamides and biphenylsulfonamides.
    Liao Y; Böttcher H; Harting J; Greiner H; van Amsterdam C; Cremers T; Sundell S; März J; Rautenberg W; Wikström H
    J Med Chem; 2000 Feb; 43(3):517-25. PubMed ID: 10669578
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.
    Varin T; Gutiérrez-de-Terán H; Castro M; Brea J; Fabis F; Dauphin F; Aqvist J; Lepailleur A; Perez P; Burgueño J; Vela JM; Loza MI; Rodrigo J
    Br J Pharmacol; 2010 Mar; 159(5):1069-81. PubMed ID: 19922537
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neural 5-HT4 receptors in the human isolated detrusor muscle: effects of indole, benzimidazolone and substituted benzamide agonists and antagonists.
    Candura SM; Messori E; Franceschetti GP; D'Agostino G; Vicini D; Tagliani M; Tonini M
    Br J Pharmacol; 1996 Aug; 118(8):1965-70. PubMed ID: 8864530
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Combined CoMFA and CoMSIA 3D-QSAR study of benzimidazole and benzothiophene derivatives with selective affinity for the CB2 cannabinoid receptor.
    Romero-Parra J; Chung H; Tapia RA; Faúndez M; Morales-Verdejo C; Lorca M; Lagos CF; Di Marzo V; David Pessoa-Mahana C; Mella J
    Eur J Pharm Sci; 2017 Apr; 101():1-10. PubMed ID: 28137469
    [TBL] [Abstract][Full Text] [Related]  

  • 71. 3D-QSAR analysis on benzazole derivatives as eukaryotic topoisomerase II inhibitors by using comparative molecular field analysis method.
    Temiz-Arpaci O; Tekiner-Gulbas B; Yildiz I; Aki-Sener E; Yalcin I
    Bioorg Med Chem; 2005 Dec; 13(23):6354-9. PubMed ID: 15993083
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Application of ligand SAR, receptor modeling and receptor mutagenesis to the discovery and development of a new class of 5-HT(2A) ligands.
    Westkaemper RB; Glennon RA
    Curr Top Med Chem; 2002 Jun; 2(6):575-98. PubMed ID: 12052195
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A combination of 3D-QSAR, molecular docking and molecular dynamics simulation studies of benzimidazole-quinolinone derivatives as iNOS inhibitors.
    Zhang H; Zan J; Yu G; Jiang M; Liu P
    Int J Mol Sci; 2012; 13(9):11210-11227. PubMed ID: 23109848
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Molecular interaction of the antagonist N-(piperidin-1-yl)-5-(4-chlorophenyl)-1- (2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide with the CB1 cannabinoid receptor.
    Shim JY; Welsh WJ; Cartier E; Edwards JL; Howlett AC
    J Med Chem; 2002 Mar; 45(7):1447-59. PubMed ID: 11906286
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel 5-hydroxytryptamine (5-HT3) receptor antagonists. III. Pharmacological evaluations and molecular modeling studies of optically active 4,5,6,7-tetrahydro-1H-benzimidazole derivatives.
    Ohta M; Suzuki T; Furuya T; Kurihara H; Tokunaga T; Miyata K; Yanagisawa I
    Chem Pharm Bull (Tokyo); 1996 Sep; 44(9):1707-16. PubMed ID: 8855365
    [TBL] [Abstract][Full Text] [Related]  

  • 76. 2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors.
    Glennon RA; Lee M; Rangisetty JB; Dukat M; Roth BL; Savage JE; McBride A; Rauser L; Hufeisen S; Lee DK
    J Med Chem; 2000 Mar; 43(5):1011-8. PubMed ID: 10715164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Synthesis, binding properties and receptor docking of 4-halo-6-[2-(4-arylpiperazin-1-yl)ethyl]-1H-benzimidazoles, mixed ligands of D2 and 5-HT1A receptors.
    Andrić D; Roglić G; Sukalović V; Soskić V; Kostić-Rajacić S
    Eur J Med Chem; 2008 Aug; 43(8):1696-705. PubMed ID: 18006194
    [TBL] [Abstract][Full Text] [Related]  

  • 78. 3D QSAR analyses-guided rational design of novel ligands for the (alpha4)2(beta2)3 nicotinic acetylcholine receptor.
    Gohlke H; Schwarz S; Gündisch D; Tilotta MC; Weber A; Wegge T; Seitz G
    J Med Chem; 2003 May; 46(11):2031-48. PubMed ID: 12747776
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modeling of the D2 dopamine receptor arylpiperazine binding site for 1-[2-[5-(1H-benzimidazole-2-thione)]ethyl]-4-arylpiperazines.
    Sukalović V; Zlatović M; Andrić D; Roglić G; Kostić-Rajaccić S; Soskić V
    Arch Pharm (Weinheim); 2004 Sep; 337(9):502-12. PubMed ID: 15362123
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 5-HT4 receptor ligands: applications and new prospects.
    Langlois M; Fischmeister R
    J Med Chem; 2003 Jan; 46(3):319-44. PubMed ID: 12540230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.